Cargando…
Eukaryotic initiation factor 5A2 and human digestive system neoplasms
Eukaryotic initiation factor 5A2 (eIF5A2), as one of the two isoforms in the family, is reported to be a novel oncogenic protein that is involved in multiple aspects of many types of human cancer. Overexpression or gene amplification of EIF5A2 has been demonstrated in many cancers. Accumulated evide...
Autores principales: | Meng, Qing-Bin, Peng, Jing-Jing, Qu, Zi-Wei, Zhu, Xiao-Min, Wen, Zhang, Kang, Wei-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580320/ https://www.ncbi.nlm.nih.gov/pubmed/31236196 http://dx.doi.org/10.4251/wjgo.v11.i6.449 |
Ejemplares similares
-
Solute carrier transporters: potential targets for digestive system neoplasms
por: Xie, Jing, et al.
Publicado: (2018) -
Overexpression of Eukaryotic Translation Initiation Factor 5A2 (EIF5A2) Correlates with Cell Aggressiveness and Poor Survival in Gastric Cancer
por: Meng, Qing-Bin, et al.
Publicado: (2015) -
Progress in immunotherapy for neuroendocrine neoplasm of the digestive system
por: Pan, Wei-Xuan, et al.
Publicado: (2023) -
Roles of Eukaryotic Initiation Factor 5A2 in Human Cancer
por: Wang, Feng-wei, et al.
Publicado: (2013) -
From Prokaryotes to Eukaryotes: Insights Into the Molecular Structure of Glycogen Particles
por: Liu, Qing-Hua, et al.
Publicado: (2021)